FF 400 mcg
Sponsors
GlaxoSmithKline
Conditions
AsthmaPulmonary Disease, Chronic Obstructive
Phase 1
To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)
CompletedNCT01725685
Start: 2012-11-08End: 2013-01-02Updated: 2017-06-09
Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses
CompletedNCT01894386
Start: 2013-07-15End: 2013-09-26Updated: 2017-05-15